A CUNY study identifies a unique histone tag in adult OPCs, potentially leading to myelin repair therapies for multiple sclerosis, Alzheimer's, and schizophrenia.

A groundbreaking study from the CUNY Graduate Center's Advanced Science Research Center has identified a unique histone tag in adult oligodendrocyte progenitor cells (OPCs), which may lead to innovative therapies targeting myelin repair. This discovery addresses a long-standing challenge in neurobiology by providing a clearer understanding of OPC proliferation in the adult brain, paving the way for more effective therapies to repair myelin damage and improve patient outcomes. The findings could help researchers develop treatments for conditions including multiple sclerosis, Alzheimer's disease, and schizophrenia.

August 12, 2024
4 Articles